Antimicrobial resistance testing of Helicobacter pylori: A comparison of Etest and disk diffusion methods

被引:37
作者
Midolo, PD
Bell, JM
Lambert, JR
Turnidge, JD
Grayson, ML
机构
[1] Monash Med Ctr, Dept Microbiol & Infect Dis, Clayton, Vic 3168, Australia
[2] Womens & Childrens Hosp, Dept Microbiol & Infect Dis, Adelaide, SA, Australia
[3] Mornington Peninsula Hosp, Gastroenterol Res Grp, Melbourne, Vic, Australia
关键词
Helicobacter pylori; Etest; disk diffusion; antimicrobial resistance;
D O I
10.1080/00313029700169415
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Routine antimicrobial resistance testing of Helicobacter pylori is more commonly performed since the correlation between metronidazole resistance and failure to eradicate using this drug, has been made. While resistance testing of H. pylori by Etest is simple to perform, it is expensive compared to disk diffusion methods. In this study the Etest was compared with a modified Kirby-Bauer disk diffusion (NCCLS) method for routine resistance screening of H. pylori. Fifty one pre-treatment isolates were tested against amoxycillin, metronidazole, tetracycline and erythromycin by both Etest and disk diffusion using NCCLS guideline strength disks. Clarithromycin was tested by Etest only. Nitroimidazole and macrolide resistance were detected using the modified Kirby-Bauer disk diffusion method which correlated with Etest minimum inhibitory concentration (MIG). Resistance rates were 49% for metronidazole and 8% for clarithromycin. Cross resistance occurs with macrolides against H. pylori and allows testing of erythromycin to predict resistance to clarithromycin. The very low MICs obtained with H. pylori against amoxycillin and tetracycline require the use of Etest or lower strength disk methods to be used.
引用
收藏
页码:411 / 414
页数:4
相关论文
共 16 条
[1]  
BELL GD, 1992, ALIMENT PHARM THERAP, V6, P427
[2]   HELICOBACTER-PYLORI - THE PLACE OF THE NEW MACROLIDES IN THE ERADICATION OF THE BACTERIA IN PEPTIC-ULCER DISEASE [J].
BURETTE, A ;
GLUPCZYNSKI, Y .
INFECTION, 1995, 23 :S44-S52
[3]  
Cayla R., 1995, Gut, V37, pA55
[4]   METRONIDAZOLE SUSCEPTIBILITY TESTING FOR HELICOBACTER-PYLORI - COMPARISON OF DISK, BROTH, AND AGAR DILUTION METHODS AND THEIR CLINICAL RELEVANCE [J].
DECROSS, AJ ;
MARSHALL, BJ ;
MCCALLUM, RW ;
HOFFMAN, SR ;
BARRETT, LJ ;
GUERRANT, RL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (08) :1971-1974
[5]  
GLUPCZYNSKI Y, 1992, EUR J CLIN MICROBIOL, V11, P777
[6]   EVALUATION OF THE E-TEST FOR QUANTITATIVE ANTIMICROBIAL SUSCEPTIBILITY TESTING OF HELICOBACTER-PYLORI [J].
GLUPCZYNSKI, Y ;
LABBE, M ;
HANSEN, W ;
CROKAERT, F ;
YOURASSOWSKY, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (09) :2072-2075
[7]  
GLUPCZYNSKI Y, 1993, ZBL BAKT-INT J MED M, V280, P227
[8]  
Glupczynski Y., 1995, Gut, V37, pA56
[9]   COMPARISON OF 3 METHODS FOR THE DETERMINATION OF THE SENSITIVITY OF HELICOBACTER-PYLORI TO METRONIDAZOLE [J].
HIRSCHL, AM ;
HIRSCHL, MM ;
ROTTER, ML .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (01) :45-49
[10]   INVITRO ACTIVITY OF METRONIDAZOLE AGAINST HELICOBACTER-PYLORI AS DETERMINED BY AGAR DILUTION AND AGAR DIFFUSION [J].
KNAPP, CC ;
LUDWIG, MD ;
WASHINGTON, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (06) :1230-1231